Search research articles
Contact Us
Filters
Showing results (51-60 of 140) with videos related to
Page
of 14
Sort By:
Breast Cancer Research and Treatment
|
September 27, 2020
Efficacy of anti-HER2 therapy in metastatic breast cancer by discordance of HER2 expression between primary and metastatic breast cancer
Elisa Van Raemdonck, G Floris, P Berteloot, et al.
Gynecologic and Obstetric Investigation
|
October 10, 2008
Limited clinical benefit from trastuzumab in recurrent endometrial cancer: two case reports
I Vandenput, I Vanden Bempt, K Leunen, et al.
Cancer Research
|
April 1, 1996
Lack of genotoxicity of tamoxifen in human endometrium
P L Carmichael, A H Ugwumadu, P Neven, et al.
Journal De Pharmacie De Belgique
|
June 25, 1999
BM 144: an original thromboxane A2 receptor antagonist derived from torasemide
J M Dogné, P Neven, J Damas, et al.
Breast Cancer Research and Treatment
|
March 18, 2008
Delivery of adjuvant sequential dose-dense FEC-Doc to patients with breast cancer is feasible, but dose reductions and toxicity are dependent on treatment sequence
H Wildiers, L Dirix, P Neven, et al.
Climacteric : the Journal of the International Menopause Society
|
November 28, 2014
Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer
S Buchholz, M Mögele, A Lintermans, et al.
Acta Psychiatrica Scandinavica
|
June 27, 2015
Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review
M De Hert, J Peuskens, T Sabbe, et al.
Clinical Chemistry
|
September 1, 1993
Substantial urinary concentrations of material resembling beta-core fragment of chorionic gonadotropin beta-subunit in mid-menstrual cycle
P Neven, R K Iles, I Howes, et al.
Breast (Edinburgh, Scotland)
|
February 18, 2014
Prognostic implications of lobular breast cancer histology: new insights from a single hospital cross-sectional study and SEER data
O Brouckaert, A Laenen, A Smeets, et al.
British Journal of Cancer
|
July 2, 2009
Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?
I Vandenput, B Van Calster, A Capoen, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 140) with videos related to
Sort By:
Page
of 14
Breast Cancer Research and Treatment
|
September 27, 2020
Efficacy of anti-HER2 therapy in metastatic breast cancer by discordance of HER2 expression between primary and metastatic breast cancer
Elisa Van Raemdonck, G Floris, P Berteloot, et al.
Gynecologic and Obstetric Investigation
|
October 10, 2008
Limited clinical benefit from trastuzumab in recurrent endometrial cancer: two case reports
I Vandenput, I Vanden Bempt, K Leunen, et al.
Cancer Research
|
April 1, 1996
Lack of genotoxicity of tamoxifen in human endometrium
P L Carmichael, A H Ugwumadu, P Neven, et al.
Journal De Pharmacie De Belgique
|
June 25, 1999
BM 144: an original thromboxane A2 receptor antagonist derived from torasemide
J M Dogné, P Neven, J Damas, et al.
Breast Cancer Research and Treatment
|
March 18, 2008
Delivery of adjuvant sequential dose-dense FEC-Doc to patients with breast cancer is feasible, but dose reductions and toxicity are dependent on treatment sequence
H Wildiers, L Dirix, P Neven, et al.
Climacteric : the Journal of the International Menopause Society
|
November 28, 2014
Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer
S Buchholz, M Mögele, A Lintermans, et al.
Acta Psychiatrica Scandinavica
|
June 27, 2015
Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review
M De Hert, J Peuskens, T Sabbe, et al.
Clinical Chemistry
|
September 1, 1993
Substantial urinary concentrations of material resembling beta-core fragment of chorionic gonadotropin beta-subunit in mid-menstrual cycle
P Neven, R K Iles, I Howes, et al.
Breast (Edinburgh, Scotland)
|
February 18, 2014
Prognostic implications of lobular breast cancer histology: new insights from a single hospital cross-sectional study and SEER data
O Brouckaert, A Laenen, A Smeets, et al.
British Journal of Cancer
|
July 2, 2009
Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?
I Vandenput, B Van Calster, A Capoen, et al.
Page
of 14